Novartis Vs Union of India: A Landmark Case in Intellectual Property Law
INTRODUCTION The judgment of the Supreme Court of India in the case of Novartis vs Union of India, 2013, marked a milestone at the interface between intellectual property law and public health. This landmark case has shifted thinking with respect to the perception of pharmaceutical patents vis-à-vis their impact on access to lifesaving drugs. In … Continue reading Novartis Vs Union of India: A Landmark Case in Intellectual Property Law
Read more »Patentee Rights During Pendency Of Post-Grant Opposition
Issues: In the case of Novartis AG & ANR v Natco Pharma Ltd, Swiss Pharma major Novartis has been granted patent for novel and inventive compound “Certinib” for treatment of non-small cell lung cancer. The suit patent was filed claiming priority since 2007, and was granted on 28th September, 2015. Novartis came across NOXALK (Natco … Continue reading Patentee Rights During Pendency Of Post-Grant Opposition
Read more »